Brief: Clearside Biomedical’S Suprachoroidal Injection Platform Featured At The Angiogenesis, Exudation, And Degeneration 2022 Virtual Conference
14/02/2022 21:05
Feb 14 (Reuters) - Clearside Biomedical Inc CLSD.O :
* CLEARSIDE BIOMEDICAL’S SUPRACHOROIDAL INJECTION PLATFORM FEATURED AT THE
ANGIOGENESIS, EXUDATION, AND DEGENERATION 2022 VIRTUAL CONFERENCE
Source text for Eikon: ID:nGNX5jlk7H
Further company coverage: CLSD.O
Recent news on Clearside Biomedical,
See all newsBrief: Clearside Biomedical Completes Financial Restructuring And Emerges From Chapter 11 With Steel Partners As Plan Sponsor
U.S. STOCKS ON THE MOVE-Merck, Genco, Tesla
U.S. STOCKS ON THE MOVE-Morgan Stanley, Merck, Genco
Clearside Biomedical plunges after filing for Chapter 11 bankruptcy
U.S. STOCKS ON THE MOVE-Bristol Myers Squibb, Palo Alto Networks, MP Materials